Nucleic Acid Therapeutics: State of the Art and Future Prospects
Open Access
- 1 August 1998
- journal article
- Published by American Society of Hematology in Blood
- Vol. 92 (3), 712-736
- https://doi.org/10.1182/blood.v92.3.712
Abstract
No abstract availableKeywords
This publication has 228 references indexed in Scilit:
- In VivoTransfer Efficiency of Antisense Oligonucleotides into the Myocardium Using HVJ–Liposome MethodBiochemical and Biophysical Research Communications, 1997
- Kinetic Selectivity of Complementary Nucleic Acids:bcr-abl-directed Antisense RNA and RibozymesJournal of Molecular Biology, 1996
- The state of the art in antisense researchNature Medicine, 1995
- Site and Mechanism of Antisense Inhibition by C-5 Propyne OligonucleotidesBiochemistry, 1995
- Efficient Unwinding of Triplex DNA by a DNA HelicaseBiochemical and Biophysical Research Communications, 1994
- In vitro inhibition of the pim-1 protooncogene by chimeric oligodeoxyribonucleotides composed of a- and β-anomeric fragmentsGene, 1994
- Oligonucleotides in the treatment of leukemiaHematological Oncology, 1994
- Antisense technologyCurrent Opinion in Biotechnology, 1991
- Studies on the hammerhead RNA self-cleaving domainGene, 1989
- Viral myb oncogene encodes a sequence-specific DNA-binding activityNature, 1988